6140-63-2

Basic information

• Product Name: Cyclopentanecarboxaldehyde, 1-methyl-
• Synonyms: 1-methylcyclopentanecarbaldehyde;1-Methyl-cyclopentancarbaldehyd;1-Methyl-1-cyclopentancarboxaldehyd;1-methyl-1-cyclopentanecarbaldehyde;1-Methyl-cyclopentan-1-carboxaldehyd;1-methyl-1-cyclopentanecarboxaldehyde
• CAS NO: 6140-63-2
• Molecular Formula: C7H12O
• Molecular Weight: 112.172
• Mol File: 6140-63-2.mol
• Article Data: 14

Chemical Properties

• Boiling Point: 511.5oC at 760 mmHg
• Flash Point: 263.2oC
• Density: 1.47g/cm3
• CAS DataBase Reference: Cyclopentanecarboxaldehyde, 1-methyl-(CAS DataBase Reference)
• NIST Chemistry Reference: Cyclopentanecarboxaldehyde, 1-methyl-(6140-63-2)
• EPA Substance Registry System: Cyclopentanecarboxaldehyde, 1-methyl-(6140-63-2)

Safety Data

• Hazardous Substances Data: 6140-63-2(Hazardous Substances Data)

Usage

Synthesis Reference(s)

Journal of the American Chemical Society, 90, p. 4193, 1968 DOI: 10.1021/ja01017a071Tetrahedron Letters, 35, p. 3763, 1994 DOI: 10.1016/S0040-4039(00)73093-0

Upstream product

• 81560-73-8 (1-methyl-cyclopentyl)-glyoxylic acid 
• 64-18-6 formic acid 
• 108-93-0 cyclohexanol 
• 5763-53-1 1,1-bis-(hydroxymethyl)cyclopentane 
• 1713-33-3 1,2-epoxy-1-methylcyclohexane 
• 4254-02-8 cyclopentanecarbonitrile 
• 64871-70-1 1-methylcyclopentane-1-carbonitrile 
• 5217-05-0 1-methylcyclopentanecarboxylic acid 
• 4630-80-2 methyl cyclopentane carboxylate 
• 4630-83-5 methyl 1-methylcyclopentanecarboxylate 
• 38502-28-2 (1-methylcyclopentyl)methanol 
• 56-23-5 tetrachloromethane 
• 14977-61-8 chromyl chloride 
• 82166-21-0 methyl cyclohexane 

Downstream Products

• 583-60-8 2-Methylcyclohexanone 
• 1414368-12-9 N-[4-hydroxy-4-(1-methylcyclopentyl)but-2-ynyl]-N-(prop-2-ynyl)-4-methylbenzenesulfonamide 
• 1414368-29-8 dimethyl 2-[4-(1-methylcyclopentyl)-2-phenylsulfonyl-2,3-butadienyl]-2-(prop-2-ynyl)malonate 
• 1414368-30-1 1-(1-methylcyclopentyl)-3,5,5-tris(phenylsulfonyl)octa-1,2-dien-7-yne 
• 1414368-31-2 5,5-bis(methoxymethyl)-1-(1-methylcyclopentyl)-3-phenylsulfonylocta-1,2-dien-7-yne 
• 1414368-32-3 2,2-dimethyl-5-[4-(1-methylcyclopentyl)-2-phenylsulfonylbuta-2,3-dienyl]-5-(prop-2-ynyl)-1,3-dioxane 
• 1414368-35-6 1-(1-methylcyclopentyl)-3-phenylsulfonylocta-1,2-dien-7-yne 
• 1414368-36-7 N-[4-(1-methylcyclopentyl)-2-phenylsulfonylbuta-2,3-dienyl]-N-(prop-2-ynyl)-4-methylbenzenesulfonamide 
• 1414368-47-0 dimethyl 2-{[4-2H]-4-(1-Methylcyclopentyl)-2-phenylsulfonylbuta-2,3-dienyl}-2-(prop-2-ynyl)malonate 
• 1414368-33-4 5,5-bis(hydroxymethyl)-1-(1-methylcyclopentyl)-3-phenylsulfonylocta-1,2-dien-7-yne 
• 1414368-34-5 1-(1-methylcyclopentyl)-5,5-bis(4-nitrobenzoyloxymethyl)-3-phenylsulfonylocta-1,2-dien-7-yne 
• 1414368-41-4 dimethyl 2-[2-benzyl-4-(1-methylcyclopentyl)buta-2,3-dienyl]-2-(prop-2-ynyl)malonate 
• 1414368-45-8 5,5-bis(4-chlorobenzoyloxymethyl)-1-(1-methylcyclopentyl)-3-phenylsulfonylocta-1,2-dien-7-yne 
• 1414368-48-1 (2Z,8Z)-11,11-bis(methoxycarbonyl)-3-methyl-13-phenylsulfonylbicyclo[7.4.0]trideca-1⁽¹³⁾,2,8-triene 

Relevant articles and documents

N-SUBSTITUTED-DIOXOCYCLOBUTENYLAMINO-3-HYDROXY-PICOLINAMIDES USEFUL AS CCR6 INHIBITORS

The present invention relates to N-substituted-dioxocyclobutenylamino-3-hydroxy-picolinamide compounds of Formulae (IA and 1B) or a pharmaceutically acceptable salt or hydrate thereof, that inhibit CC chemokine receptor 6 (CCR6), pharmaceutical compositions containing these compounds, and the use of these compounds for treating or preventing diseases, conditions, or disorders ameliorated by inhibition of CCR6.

PYRROLOPYRIMIDINES FOR USE IN INFLUENZA VIRUS INFECTION

The invention relates to compounds having the structure of formula (I) which can be used for the treatment of or against influenza infections.

INHIBITORS OF INFLUENZA VIRUSES REPLICATION

Methods of inhibiting the replication of influenza viruses in a biological sample or patient, of reducing the amount of influenza viruses in a biological sample or patient, and of treating influenza in a patient, comprises administering to said biological sample or patient an effective amount of a compound represented by Structural Formula (I): or a pharmaceutically acceptable salt thereof, wherein the values of Structural Formula (I) are as described herein. A compound is represented by Structural Formula (I) or a pharmaceutically acceptable salt thereof, wherein the values of Structural Formula (I) are as described herein. A pharmaceutical composition comprises an effective amount of such a compound or pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier, adjuvant or vehicle.